Wound Heal Clinical Trial
Official title:
Optimization Program for the Care Management of Difficult-to-heal Postoperative Wounds Based on TIME CDST Tool:a Randomized Controlled Trial Protocol
Verified date | February 2024 |
Source | Tongji Hospital |
Contact | Danni Feng |
Phone | 0086-13476022370 |
992911819[@]qq.com | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to investigate the effectiveness of an optimized care management protocol for refractory postoperative wounds based on the TIME CDST tool. Through a randomized controlled trial approach, the investigators will conduct a rigorous comparative analysis of the experimental group and the control group. The intervention group will receive an intervention plan based on the TIME CDST tool led by wound specialist nurses at each dressing change, while the control group receive a routine wound care program of wound cleaning and dressing changes at each dressing change. The main research objective is to evaluate the superiority of the experimental group compared with the control group in terms of wound healing time, healing quality, and patient satisfaction. Through the implementation of this study, the investigators expect to provide an effective optimization scheme for the management of refractory postoperative wounds in clinical practice, thereby improving patient outcomes and quality of life.
Status | Not yet recruiting |
Enrollment | 144 |
Est. completion date | November 15, 2024 |
Est. primary completion date | October 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - age =18 years; - wound healing time after surgery more than 2 weeks; - patients have normal cognitive and communication skills; - patients are able to cooperate with relevant nursing measures; - patients voluntarily participate in this trial and sign the informed consent form. Exclusion Criteria: - patients are severe malnutrition or obesity; - patients combine with other infectious diseases; - patients with comorbid malignancies, severe endocrine and hematologic diseases; - patients combine with heart, liver, kidney and other organ dysfunction; - patients combine with autoimmune diseases. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Danni Feng |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Wound healing time | Wound healing time will be assessed as the primary outcome indicator. Complete epithelialization of the wound is considered as wound healing and the time taken from enrollment to complete wound healing will be recorded for both groups. | The time frame is from the date of intervention until the date of the complete healing of the wound or date of death from any cause, whichever came first, assessed up to 6 months. | |
Secondary | The wound healing rate | The wound healing rate will be measured by using the number of wound healing cases during the follow-up period/total number of cases × 100%. | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | The rate of wound area reduction | The rate of wound area reduction will be calculated through the following expression: (original wound area - present wound area)/original wound area × 100%. The accuracy of wound area measurements can be improved by placing a uniform wound measuring tape on one side of the wound and taking a picture of the wound area using image processing and analysis with Image J software (National Institutes of Health, Bethesda, MD). | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | The Pressure Ulcer Scale for Healing (PUSH) | The Pressure Ulcer Scale for Healing (PUSH) will objectively and dynamically assess the healing of all types of acute and chronic wounds in terms of wound area, the amount of exudate, and the type of wound tissue, with scores ranging from 0 to 17, with a decreasing total score implying that treatment is effective, an increasing total score implying that wound deterioration is occurring, and an unchanged total score implying that treatment is ineffective. | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | The positive rate of bacterial culture | The positive rate of bacterial culture in each group will be calculated through the following expression: current number of positive bacterial culture cases/ total number of cases × 100%. | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | The pain intensity | The pain intensity is evaluated using the visual analogue scale (VAS). In the absence of pain, a score of 0 represents a painless state; a score of 1 to 3 represents mild pain; a score of 4 to 6 represents moderate pain; and a score of 7 to 10 represents severe pain. | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | Patient comfort score | Use a self-made nursing comfort questionnaire to evaluate the patient's nursing comfort. The questionnaire was conducted on a 10 point scale, with scores>9 indicating extreme comfort, 8-9 indicating relative comfort, 6-7 indicating basic comfort, and<6 indicating discomfort. | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | Patient satisfaction score | Use a self-made nursing satisfaction questionnaire to evaluate the patient's nursing satisfaction. Both questionnaires were conducted on a 10 point scale, with scores>9 indicating very satisfied, 8-9 indicating relative satisfaction, 6-7 indicating basic satisfaction, and<6 indicating dissatisfaction. | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | The levels of albumin | Albumin count | At 1, 2, 4, 6 and 8 weeks after the intervention begins | |
Secondary | The number of dressing changes | The number of dressing changes | The time frame is from the date of intervention until the date of the complete healing of the wound or date of death from any cause, whichever came first, assessed up to 6 months. | |
Secondary | Medical costs | Medical cost expenditure | The time frame is from the date of intervention until the date of the complete healing of the wound or date of death from any cause, whichever came first, assessed up to 6 months. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Recruiting |
NCT03459547 -
Soft Peri-implant Tissue Around Different Abutment Materials
|
N/A | |
Recruiting |
NCT05608187 -
Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
|
Phase 2 | |
Active, not recruiting |
NCT03649308 -
Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting
|
N/A | |
Recruiting |
NCT04596124 -
Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze
|
N/A | |
Completed |
NCT03285542 -
Prospective Randomized Trial of Dermabond Prineo in Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05474911 -
PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.
|
N/A | |
Recruiting |
NCT05689775 -
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
|
||
Recruiting |
NCT04849143 -
The Effectiveness of Stingless Bee Honey (Kelulut Honey) Versus Gel in Diabetic Wound Bed Preparation
|
N/A | |
Completed |
NCT03596112 -
The Difference in Wound Size Reduction Comparing Two Frequently Used Wound Dressings in Everyday Care
|
N/A | |
Recruiting |
NCT05169814 -
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
|
Early Phase 1 | |
Completed |
NCT04545476 -
Enhanced Secondary Intention Healing vs. Standard Secondary Intention Healing in Mohs Surgical Defects on the Head and Distal Lower Extremities
|
N/A | |
Completed |
NCT06020157 -
Comparison of Simple and Continuous Suture Techniques in Oral Surgery
|
N/A | |
Recruiting |
NCT05133570 -
Study Evaluating the Effectiveness of Treatment With Vista Care®, in Arterial Ulcers of the Lower Extremities
|
||
Recruiting |
NCT04901325 -
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
|
Phase 2 | |
Withdrawn |
NCT03668665 -
Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design"
|
Phase 3 | |
Completed |
NCT03703479 -
Effect of A-PRF After Removal of Wisdom Teeth
|
N/A | |
Recruiting |
NCT03204851 -
Microlyte Dressing in the Management of Wounds
|
N/A | |
Recruiting |
NCT06117436 -
Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients
|
Phase 2/Phase 3 | |
Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A |